{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper explains that mutations in the LRRK2 gene cause autosomal dominant Parkinson's disease. The LRRK2 protein has a ROC GTPase and a kinase domain linked by the C-terminal of ROC (COR) domain, and the Y1699C pathogenic mutation affects this COR domain.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the LRRK2 Y1699C variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses a protein interaction assay to study the effects of the Y1699C mutation on LRRK2 protein interactions, which is a common method for studying disease-causing mutations that affect protein interactions.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used for this variant (protein interaction assay) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_name": "3a: Basic Controls and Replicates",
              "questions": [
                {
                  "question_1": "Were basic controls included for this assay? Specifically, were 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "question_2": "Did the paper explicitly state that multiple replicates were used for the experiments?"
                },
                {
                  "answer_1": "Yes",
                  "answer_2": "Yes"
                }
              ],
              "judgment": "Both conditions met"
            },
            {
              "sub_step_name": "3c: Variant Controls",
              "questions": [
                {
                  "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls?"
                },
                {
                  "answer": "Yes"
                }
              ],
              "judgment": "Condition met"
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "sub_step_name": "4a: Statistical Analyses",
              "questions": [
                {
                  "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?"
                },
                {
                  "answer": "Yes"
                }
              ],
              "judgment": "Condition met"
            },
            {
              "sub_step_name": "4c: Correlate OddsPath",
              "questions": [
                {
                  "question": "What is the calculated OddsPath value for this variant?"
                },
                {
                  "answer": "Not provided"
                }
              ],
              "judgment": "OddsPath not provided",
              "additional_info": "Assuming standard thresholds: Since OddsPath is not provided, the functional evidence strength cannot be determined based on this criterion."
            }
          ]
        }
      ],
      "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting"
    }
  ]
}